Israeli research confirms BNT162b2 booster's effectiveness - News-Medical.Net

Researchers explore the use of a third dose of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

As of April 7, 2022, coronavirus disease 2019 (COVID-19) has caused over 6.16 million deaths worldwide. Soon after the emergence of the causative agent of COVID-19, the severe acute respiratory syndr… [+5388 chars]

full article...